What is Riverfield?
Riverfield, a venture company originating from a national university, is at the forefront of medical robotics, leveraging advanced technology to create new value that supports human life and industry. The company's core focus lies in exploring the infinite possibilities of robotics, particularly in developing products designed to assist in high-quality, minimally invasive surgeries. These innovations prioritize safety and reliability for both patients and medical professionals, reflecting a deep commitment to advancing healthcare through cutting-edge solutions.
How much funding has Riverfield raised?
Riverfield has raised a total of $12.1M across 2 funding rounds:
Series A
$2M
Series B
$10.1M
Series A (2014): $2M, investors not publicly disclosed
Series B (2017): $10.1M led by Toray Engineering
Key Investors in Riverfield
Toray Engineering
Toray Engineering Co Ltd is a company operating in the Architecture, Engineering & Design industry, likely bringing expertise in advanced manufacturing and engineering solutions to its portfolio companies.
What's next for Riverfield?
The substantial enterprise-level funding Riverfield has garnered, particularly the recent major strategic investment, signals a pivotal phase for the company's growth and market expansion. This capital infusion is expected to accelerate the development and deployment of their sophisticated surgical robotics, potentially enabling broader adoption in healthcare systems and further exploration of robotic applications beyond the medical field. Riverfield's trajectory suggests a strong focus on scaling its operations and solidifying its leadership in the high-tech medical device industry.
See full Riverfield company page
